The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10701 malaria professionals are enjoying the free benefits of MalariaWorld today

anti malarial drugs

Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs

January 15, 2019 - 15:26 -- Open Access
Tags: 
plasmodium falciparum
Author(s): 
Takahiro Tougan, Yuji Toya, Kinya Uchihashi and Toshihiro Horii
Reference: 
Malaria Journal 2019 18:8, 14 January 2019

The current study demonstrates that the XN-30 analyzer objectively, reproducibly, and easily evaluated and characterized the anti-malarial efficacy of various compounds.

Medical Treatment: 
anti malarial drugs

Appropriateness of malaria diagnosis and treatment for fever episodes according to patient history and anti-malarial blood measurement: a cross-sectional survey from Tanzania

May 22, 2018 - 14:12 -- Open Access
Tags: 
malaria
Author(s): 
Joanna Gallay, Dominic Mosha, Erick Lutahakana, Festo Mazuguni, Martin Zuakulu, Laurent Arthur Decosterd, Blaise Genton and Emilie Pothin
Reference: 
Malaria Journal 2018 17:209, 21 May 2018

This study showed high prevalence of circulating anti-malarial drug in the sampled population.

Country: 
Tanzania
Medical Treatment: 
anti malarial drugs

NOT Open Access | Antimalarial, hematological, and antioxidant effects of methanolic extract of Terminalia avicennioides in Plasmodium berghei-infected mice

September 18, 2013 - 12:43 -- NOT Open Access
Tags: 
plasmodium berghei
Author(s): 
Akhere A. Omonkhua , Mojisola C. Cyril-Olutayo , Olusegun M. Akanbi & Olayinka A. Adebayo
Reference: 
Parasitology Research, October 2013, Volume 112, Issue 10, pp 3497-3503
MalariaWorld

Terminalia avicennioides Guill. & Perr. (Combretaceae) is used traditionally to treat malaria in Nigeria.

Country: 
Nigeria
Medical Treatment: 
anti malarial drugs

Should New Antimalarial Drugs Be Subsidized?

March 17, 2010 - 10:18 -- Ingeborg van Schayk
Author(s): 
Ramanan Laxminarayan, Ian W.H. Parry, David L. Smith, Eili Y. Klein
Reference: 
Journal of Health Economics, In Press, Accepted Manuscript, Available online 7 March 2010

This paper develops a conceptual and numerical framework for understanding the conditions under which subsidies for artemisinin combinations can be justified on economic efficiency grounds.

Technology: 
subsidy
Medical Condition: 
malaria
Medical Treatment: 
anti malarial drugs
Subscribe to RSS - anti malarial drugs